Gastric Cancer

• CLINICAL_TRIALS trial_result · 2024-04-15
  Clinical Trial Update: Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer [Phase 2]

  Phase 2 clinical trial evaluating HLX22 combined with trastuzumab and chemotherapy versus placebo with trastuzumab and chemotherapy for loca…

• CLINICAL_TRIALS trial_result · 2024-04-05
  Clinical Trial Update: Chemoprevention of Gastric Carcinogenesis [Phase 2]

  A Phase 2 chemoprevention trial for gastric carcinogenesis has completed; results have been posted.

• CLINICAL_TRIALS trial_result · 2024-04-03
  Clinical Trial Update: DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy [Phase 2, Phase 3]

  Phase 2/3 trial evaluating DV in combination with cadonilimab for HER2-expressing gastric cancer and gastroesophageal junction adenocarcinom…

• CLINICAL_TRIALS trial_result · 2024-03-27
  Clinical Trial Update: A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on First or Subsequent Line Therapies [Phase 2]

  Phase II study evaluating lenvatinib with pembrolizumab in metastatic gastroesophageal and gastric cancer after prior therapies; study compl…

• CLINICAL_TRIALS trial_result · 2024-03-25
  Clinical Trial Update: Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC [Phase 2]

  Phase 2 trial evaluating infusional fluorouracil plus weekly docetaxel in gastric cancer with bone marrow involvement and DIC; study complet…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-03-20
  Clinical Trial Update: A Study of TAS-120 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

  A Phase 1/2 study of futibatinib (TAS-120) in patients with advanced solid tumors, including cholangiocarcinoma, urothelial carcinoma, breas…

• CLINICAL_TRIALS trial_result · 2024-03-13
  Clinical Trial Update: Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED) [Phase 2]

  Phase 2 PROCEED trial evaluating pembrolizumab with radiotherapy and chemotherapy as neoadjuvant treatment for locally advanced esophageal a…

• CLINICAL_TRIALS trial_result · 2024-03-13
  Clinical Trial Update: KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer [Phase 2]

  Phase 2 trial update for KeyLargo combining pembrolizumab with oxaliplatin and capecitabine in gastric and esophageal cancer; study complete…

• CLINICAL_TRIALS trial_result · 2024-03-13
  Clinical Trial Update: Pembrolizumab + Capecitabine／Oxaliplatin (CapeOx) -HER2 Nagative and Pembrolizumab + Trastuzumab + Cisplatin/Capecitabine HER2 Positive [Phase 2]

  Phase 2 clinical trial update investigating pembrolizumab with CapeOx in HER2-negative gastric cancer and pembrolizumab with trastuzumab and…

• CLINICAL_TRIALS trial_result · 2024-03-12
  Clinical Trial Update: KN026 in Patients With HER2 Expressing Gastric/Gastroesophageal Junction Cancer [Phase 2]

  Phase 2 clinical trial update for KN026 in patients with HER2-expressing gastric/gastroesophageal junction cancer; study status completed.

• CLINICAL_TRIALS trial_result · 2024-03-12
  Clinical Trial Update: Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG [Phase 2]

  Phase 2 clinical trial comparing perioperative immunotherapy to chemo-immunotherapy in advanced gastric cancer and esophagogastric junction …

• CLINICAL_TRIALS trial_result · 2024-03-06
  Clinical Trial Update: Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence [Phase 3]

  Phase 3 clinical trial update evaluating prophylactic preoperative HIPEC to reduce peritoneal recurrence in advanced gastric cancer at high …

• CLINICAL_TRIALS trial_result · 2024-03-05
  Clinical Trial Update: Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia [Phase 2]

  Phase 2 trial assessing whether curcumin can help prevent gastric cancer in patients with chronic atrophic gastritis or gastric intestinal m…

• CLINICAL_TRIALS trial_result · 2024-02-29
  Clinical Trial Update: Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer [Phase 2]

  Phase 2 clinical trial update evaluating tirelizumab with chemotherapy for HER2-negative locally advanced gastric cancer.

• CLINICAL_TRIALS trial_result · 2024-02-28
  Clinical Trial Update: M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma. [Phase 3]

  A phase 3 trial evaluating M108 plus CAPOX versus placebo plus CAPOX as first-line treatment for CLDN18.2-positive, HER2-negative, PD-L1 CPS…

• CLINICAL_TRIALS trial_result · 2024-02-28
  Clinical Trial Update: SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma [Phase 2]

  A Phase 2 trial update evaluating SHR-1210 with trastuzumab, oxaliplatin, and capecitabine as neoadjuvant therapy for gastric adenocarcinoma…

• CLINICAL_TRIALS trial_result · 2024-02-28
  Clinical Trial Update: Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS [Phase 3]

  Phase 3 trial comparing adjuvant capecitabine to observation in curatively resected stage IB gastric cancer is currently recruiting under th…

• CLINICAL_TRIALS trial_result · 2024-02-28
  Clinical Trial Update: GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel Study [Phase 1, Phase 2]

  Clinical trial of durvalumab plus tremelimumab with paclitaxel for metastatic gastric cancer completed Phase 1/2.

• CLINICAL_TRIALS trial_result · 2024-02-28
  Clinical Trial Update: Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPH [Phase 3]

  Phase 3 trial updating adjuvant chemotherapy regimens for gastric cancer comparing Docetaxel/Capecitabine/Oxaliplatin versus Capecitabine/Ox…

• CLINICAL_TRIALS trial_result · 2024-02-26
  Clinical Trial Update: Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma [Phase 2]

  A Phase 2 clinical trial update investigates fruquintinib in combination with SOX as neoadjuvant therapy for locally advanced gastric adenoc…

• CLINICAL_TRIALS trial_result · 2024-02-15
  Clinical Trial Update: A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations [Phase 2]

  A Phase 2 clinical trial update shows results for trastuzumab deruxtecan (Enhertu) in solid tumors with HER2 activating mutations; the study…

• CLINICAL_TRIALS trial_result · 2024-02-15
  Clinical Trial Update: Perioperative Chemo and Pembrolizumab in Gastric Cancer [Phase 2]

  Phase 2 clinical trial evaluating perioperative chemotherapy with pembrolizumab for gastric cancer and gastroesophageal junction adenocarcin…

• CLINICAL_TRIALS trial_result · 2024-02-12
  Clinical Trial Update: TAS-102 and Anlotinib in ≥3 Lines mGC [Phase 2]

  Phase 2 clinical trial update evaluating TAS-102 and Anlotinib in patients with gastric cancer who have received at least three prior lines …

• CLINICAL_TRIALS trial_result · 2024-02-07
  Clinical Trial Update: The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer [Phase 2]

  A Phase 2 clinical trial evaluating chemotherapy plus camrelizumab as conversion therapy in metastatic gastric cancer has completed.

• CLINICAL_TRIALS trial_result · 2024-02-06
  Clinical Trial Update: FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma [Phase 2]

  Phase 2 trial of FOLFOX-A for metastatic or unresectable gastroesophageal junction adenocarcinoma and gastric cancer has completed with resu…